Dr. Reindollar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1809 Brenner Ave
Ste 102
Salisbury, NC 28144Phone+1 704-216-7071Fax+1 704-801-1350
Education & Training
- University of Maryland School of MedicineClass of 1975
Certifications & Licensure
- NC State Medical License 1980 - 2025
- SC State Medical License 1977 - 2005
- MD State Medical License 1978 - 2001
- FL State Medical License 1981 - 1981
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 143 citationsGlecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatmentFred Poordad, Franco Felizarta, Armen Asatryan, Mark S. Sulkowski, Robert Reindollar
Hepatology. 2017-08-01 - 120 citationsSustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeksJordan J. Feld, Christophe Moreno, Roger Trinh, Edward Tam, Suzanne Bourgeois
Journal of Hepatology. 2016-02-01 - 108 citationsGlecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.Fred Poordad, Stanislas Pol, Armen Asatryan, Maria Buti, David R. Shaw
Hepatology. 2018-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: